SUBSCRIBE
SUBSCRIBE
News   Business

GenTel BioSciences, Inc. and Eprogen, Inc. Announce Partnership to Commercialize Whole Proteome Arrays

March 11, 2009 | 
1 min read
MADISON, Wis.--(BUSINESS WIRE)--Gentel® Biosciences, a protein microarray life sciences company, announces a technology partnership with Eprogen® to create products for the discovery of new autoantibody biomarkers using whole proteome microarrays.
Alliances
MORE ON THIS TOPIC
Cairo, Egypt, October 31 2024: Novartis CO building in Egypt, Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland, manufactures the drugs
I&I
Novartis Drops up to $1B+ for Drug Discovery Deal With Matchpoint
July 24, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Illustration of employer’s hand holding employee who was laid off to drop him out of office
Layoffs
Genentech Downsizes by 87 as Priorities Shift
July 24, 2025
 · 
2 min read
 · 
Tristan Manalac
Accumulated problems, contradictions. Dead end, we need to go back. You cannot continue further. Complete impossibility to continue. Rejection of an idea. Hard sanctions. Fatal error.
Obesity
Roche Drops Early Obesity Asset, Citing Lack of Competitiveness
July 24, 2025
 · 
2 min read
 · 
Tristan Manalac
Baltimore, Maryland, skyline
Business
Maryland’s Life Sciences Scene Boasts Strong R&D, Manufacturing Talent
July 24, 2025
 · 
4 min read
 · 
Angela Gabriel